Back to Search
ANDREW BOSTOM, MD
MD
Internal Medicine Physician
NPI: 1902850274Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
MD09437(RI)
Research & Publications (20)
Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.
PMID 19022547·Am J Kidney Dis·2009
4-observational
Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.
PMID 16923411·Am Heart J·2006
4-observational
Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels.
PMID 12138147·J Am Soc Nephrol·2002
8-other
Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour.
PMID 11884295·Arterioscler Thromb Vasc Biol·2002
3-trial
Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis.
PMID 11752047·J Am Soc Nephrol·2002
4-observational
Power Shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour.
PMID 11453713·Ann Intern Med·2001
8-other
Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate.
PMID 11689224·Atherosclerosis·2001
8-other
Chronic renal transplantation: a model for the hyperhomocysteinemia of renal insufficiency.
PMID 11369018·Atherosclerosis·2001
8-other
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.
PMID 11169020·Kidney Int Suppl·2001
3-trial
Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patients.
PMID 10852611·Transplantation·2000
3-trial
Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
PMID 10859289·Circulation·2000
3-trial
Homocysteine: "expensive creatinine" or important modifiable risk factor for arteriosclerotic outcomes in renal transplant recipients?
PMID 10616851·J Am Soc Nephrol·2000
6-review
Total plasma homocysteine and arteriosclerotic outcomes in type 2 diabetes with nephropathy.
PMID 16162814·J Am Soc Nephrol·2005
4-observational
Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
PMID 16227109·J Am Acad Dermatol·2005
5-case
C-reactive protein as a predictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy.
PMID 16014055·Kidney Int·2005
3-trial
Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy.
PMID 14709365·Atherosclerosis·2004
8-other
Lipoprotein levels are associated with incident hypertension in older adults.
PMID 15161455·J Am Geriatr Soc·2004
8-other
Measures of obesity are associated with vascular stiffness in young and older adults.
PMID 12953016·Hypertension·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 593 EDDY ST, APC 9
PROVIDENCE, RI 02903 - Phone
- (401) 444-6460
Quick Facts
- NPI
- 1902850274
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile